07.26.11
INC Research and Debiopharm Group entered a strategic partnership under which INC Research will manage a clinical study for a project in Debiopharm's pipeline. Both parties have also agreed on a partnership for future clinical studies to be conducted by INC Research.
"We are pleased to offer our therapeutic expertise along with our experience in conducting trials globally to support Debiopharm's drug development efforts in bringing innovative medicines to market more quickly and efficiently," said Kelvin Logan, Ph.D., president, INC Research Europe and Asia Pacific.
"This partnership with INC Research will significantly help us in our endeavors to conduct our clinical development programs efficiently, which in turn will enable us to continue to fuel our pipeline with important new medicines," said Dr. Rolland-Yves Mauvernay, president and founder of Debiopharm.
"We are pleased to offer our therapeutic expertise along with our experience in conducting trials globally to support Debiopharm's drug development efforts in bringing innovative medicines to market more quickly and efficiently," said Kelvin Logan, Ph.D., president, INC Research Europe and Asia Pacific.
"This partnership with INC Research will significantly help us in our endeavors to conduct our clinical development programs efficiently, which in turn will enable us to continue to fuel our pipeline with important new medicines," said Dr. Rolland-Yves Mauvernay, president and founder of Debiopharm.